Histologic features and MIB-1/Ki67 indices in atypical meningiomas (GII WHO)

被引:0
|
作者
Jozefowicz, Mateusz [1 ]
Papierz, Wielislaw [1 ]
机构
[1] Zaklad Patomorfol Katedry Patomorfol Uniw Medyczn, Ul Pomorska 251, PL-92213 Lodz, Poland
来源
AKTUALNOSCI NEUROLOGICZNE | 2012年 / 12卷 / 02期
关键词
atypical meningiomas; benign meningiomas; histologic features; proliferative index;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical meningiomas are defined according WHO criteria as tumours characterized by: increased mitotic activity or three or more of the following histologic features: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, patternless or sheet like growth, and foci of "spontaneous" or "geographic" necrosis. It means, that those meningiomas which reveal only one or even two from above mentioned features are, according to WHO classification, still consistent with diagnosis of benign (GI WHO) tumours. Histologic slices from 65 atypical meningiomas were investigated and presence of each from those diagnostic histologic criteria which were mentioned above, were taken to account. Additionally, in the same way 59 benign meningiomas, which showed one or two histologic features characteristic for atypical type of the tumours, were analysed. In all cases immunohistochemical reaction with MIB-1 antibody was carried out and proliferating indices (PI) were established using image analysis computer system. Correlation between histologic criteria for atypical meningiomas and proliferating indices of the tumours was statistically estimated. We found a significant relationship between PI and mitotic activity, necrosis, small cells changes, patternless growth, nucleolies and number of histologic features that tumors present.
引用
收藏
页码:104 / 128
页数:25
相关论文
共 50 条
  • [21] Labeling of cycling corneal endothelial cells during healing with a monoclonal antibody to the Ki67 antigen (MIB-1)
    Petroll, WM
    Jester, JV
    Bean, J
    Cavanagh, HD
    CORNEA, 1999, 18 (01) : 98 - 108
  • [22] The use of Ki-67/MIB-1 immunostaining in human gliomas
    Torp, S. H.
    Mork, J. N.
    Torp, M. O.
    Skjulsvik, A. J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 : 53 - 53
  • [23] Ki-67/MIB-1 immunostaining in a cohort of human gliomas
    Skjulsvik, Anne J.
    Mork, Jorgen N.
    Torp, Morten O.
    Torp, Sverre H.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 8905 - 8910
  • [24] Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 Labeling index is a predictor for recurrence of adrenocortical carcinomas
    Morimoto, Ryo
    Satoh, Fumitoshi
    Murakami, Osamu
    Suzuki, Takashi
    Abe, Takaaki
    Tanemoto, Masayuki
    Abe, Mlchiaki
    Uruno, Akira
    Ishidoya, Shigeto
    Arai, Yoichi
    Takahashi, Kazuhiro
    Sasano, Hironobu
    Ito, Sadayoshi
    ENDOCRINE JOURNAL, 2008, 55 (01) : 49 - 55
  • [25] MIB-1, KI67, AND PCNA SCORES AND DNA FLOW-CYTOMETRY IN INTERMEDIATE GRADE MALIGNANT-LYMPHOMAS
    PICH, A
    PONTI, R
    VALENTE, G
    CHIUSA, L
    GEUNA, M
    NOVERO, D
    PALESTRO, G
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (01) : 18 - 22
  • [26] Significance of MIB-1 staining indices in meningiomas - Comparison of two counting methods
    Nakasu, S
    Li, DH
    Okabe, H
    Nakajima, M
    Matsuda, M
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (04) : 472 - 478
  • [27] Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II
    Prat-Acin, Ricardo
    Juliana Guarin-Corredor, Maria
    Galeano-Senabre, Inma
    Ayuso-Sacido, Angel
    Vera-Sempere, Francisco
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 86 : 32 - 37
  • [28] PROLIFERATION MARKERS IN GLIOMAS - A COMPARISON OF BUDR, KI-67, AND MIB-1
    DAVIS, RL
    ONDA, K
    SHUBUYA, M
    LAMBORN, K
    HOSHINO, T
    JOURNAL OF NEURO-ONCOLOGY, 1995, 24 (01) : 9 - 12
  • [29] USEFULNESS OF KI-67, CLONE MIB-1, AS A PROGNOSTIC FACTOR IN EPENDYMOMAS
    GIORDANA, MT
    CAVALLA, P
    CHIO, A
    MARINO, S
    VIGLIANI, MC
    SCHIFFER, D
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 324 - 324
  • [30] Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma
    Belderbos, Robert A.
    Maat, Alexander P. W. M.
    Baart, Sara J.
    Madsen, Eva V. E.
    Bogers, Ad J. J. C.
    Cornelissen, Robin
    Aerts, Joachim G. J. V.
    Mahtab, Edris A. F.
    von der Thuesen, Jan H.
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (04):